FDA approves first drug to specifically treat giant cell arteritis - FDA Press Releases

The U.S. Food and Drug Administration today expanded the approved use of subcutaneous Actemra (tocilizumab) to treat adults with giant cell arteritis. This new indication provides the first FDA-approved therapy, specific to this type of vasculitis.

from Food and Drug Administration--Press Releases http://ift.tt/2rtDwNK
via IFTTT